Related Experiment Videos
Mechanisms of resistance to alkylating agents
1Johns Hopkins Oncology Center, Pharmacology Laboratory, Baltimore, MD 21205.
Cancer Treatment and Research
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide.
Cancer chemotherapy and pharmacology·2001
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.
Pharmacological research·2026
Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases.
ACS chemical biology·2026